Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourLe CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Le CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Oui
$117,038 Vol.
$117,038 Vol.
31 déc. 2026
Oui
$117,038 Vol.
$117,038 Vol.
31 déc. 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Volume
$117,038Date de fin
31 déc. 2026Marché ouvert
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$117,038Date de fin
31 déc. 2026Marché ouvert
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes